Related Experiment Video

Updated: Feb 17, 2026

Reduction of Iatrogenic Atrial Septal Defects with an Anterior and Inferior Transseptal Puncture Site when Operating the Cryoballoon Ablation Catheter
08:00

Reduction of Iatrogenic Atrial Septal Defects with an Anterior and Inferior Transseptal Puncture Site when Operating the Cryoballoon Ablation Catheter

Published on: June 15, 2015

14.5K

Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy: Indications, Technical Aspects, and Clinical

Marco Spaziano, Fadi J Sawaya, Thierry Lefèvre1

  • 1Hôpital Privé Jacques Cartier, 6 Avenue du Noyer Lambert 91300, Massy, France. t.lefevre@angio-icps.com.

The Journal of Invasive Cardiology
|December 6, 2017
PubMed

Insights

Alcohol septal ablation (ASA) is a safe and effective treatment for hypertrophic obstructive cardiomyopathy (HOCM) when performed by experienced teams. This procedure offers symptom relief and comparable longevity to the general population.

Area of Science:

  • Cardiology
  • Genetics
  • Interventional Cardiology

Background:

  • Hypertrophic cardiomyopathy (HCM) is the most common inherited heart disease.
  • Two-thirds of HCM patients develop symptoms from left ventricular outflow tract obstruction.
  • Symptomatic patients with hypertrophic obstructive cardiomyopathy (HOCM) may require septal reduction therapy.

Purpose of the Study:

  • To review the indications, contraindications, and technical aspects of alcohol septal ablation (ASA).
  • To emphasize the role of imaging modalities in patient selection and procedural safety.
  • To present long-term outcomes and complication rates of ASA.

Main Methods:

  • Review of current literature on alcohol septal ablation (ASA).
  • Emphasis on echocardiography and magnetic resonance imaging for patient selection and safety.
  • Discussion of post-procedural care and potential complications.

Main Results:

  • Alcohol septal ablation (ASA) is a valuable therapeutic option for symptomatic hypertrophic obstructive cardiomyopathy (HOCM).
  • When performed by experienced teams, ASA demonstrates high success rates and low complication rates.
  • The procedure effectively relieves symptoms and contributes to similar longevity as the general population.

Conclusions:

  • Alcohol septal ablation (ASA) is a well-established and effective septal reduction therapy for hypertrophic obstructive cardiomyopathy (HOCM).
  • Adjunctive imaging is crucial for successful patient selection and safe procedure execution.
  • Long-term data support ASA as a treatment that improves quality of life and survival.

More Related Videos

Echocardiographic Evaluation of Atrial Communications before Transcatheter Closure07:41

Echocardiographic Evaluation of Atrial Communications before Transcatheter Closure

Published on: February 8, 2022

4.4K
Cox-Maze IV Procedure Concomitant with Valvular Surgery In Situs Inversus Dextrocardia: A Single-Center Experience in China08:42

Cox-Maze IV Procedure Concomitant with Valvular Surgery In Situs Inversus Dextrocardia: A Single-Center Experience in China

Published on: February 11, 2022

4.3K

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
489
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
539
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
381
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
611
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
319
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
477